APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Neutral Borosilicate Glass Packaging

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Neutral Borosilicate Glass Packaging Market Outlook and Growth Opportunities 2026

27 December 2025197 pages

Choose your research edition.

Industry ResearchPharmaceutical Neutral Borosilicate Glass Packaging Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Neutral Borosilicate Glass Packaging Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Neutral Borosilicate Glass Packaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Neutral Borosilicate Glass Packaging Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Neutral Borosilicate Glass Packaging Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Pharmaceutical Neutral Borosilicate Glass Packaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Neutral Borosilicate Glass Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Neutral Borosilicate Glass Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Neutral Borosilicate Glass Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Neutral Borosilicate Glass Packaging market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Neutral Borosilicate Glass Packaging market include Schott, Corning (Gerresheimer), NEG, Cangzhou Four Stars, Triumph Junsheng, Nipro, Chengdu Golden Drum Pharmaceutical Packaging, Chongqing Zhengchuan Pharmaceutical and Shandong Linuo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pharmaceutical Neutral Borosilicate Glass Packaging market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Neutral Borosilicate Glass Packaging and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Neutral Borosilicate Glass Packaging sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Neutral Borosilicate Glass Packaging market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Neutral Borosilicate Glass Packaging Segment by Company

Schott

Corning (Gerresheimer)

NEG

Cangzhou Four Stars

Triumph Junsheng

Nipro

Chengdu Golden Drum Pharmaceutical Packaging

Chongqing Zhengchuan Pharmaceutical

Shandong Linuo

Ningbo Zhengli

Shandong Pharmaceutical Glass

Wuhu Yangtze River Glass

Anhui Huaxin Medicinal Glass

Pharmaceutical Neutral Borosilicate Glass Packaging Segment by Type

Injection Bottle

Ampoule

Oral Bottle

Other

Pharmaceutical Neutral Borosilicate Glass Packaging Segment by Application

Pharma

Vaccine

Other

Pharmaceutical Neutral Borosilicate Glass Packaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Neutral Borosilicate Glass Packaging status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pharmaceutical Neutral Borosilicate Glass Packaging market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Neutral Borosilicate Glass Packaging significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Neutral Borosilicate Glass Packaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Neutral Borosilicate Glass Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Neutral Borosilicate Glass Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Neutral Borosilicate Glass Packaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceutical Neutral Borosilicate Glass Packaging market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Neutral Borosilicate Glass Packaging industry.

Chapter 3: Detailed analysis of Pharmaceutical Neutral Borosilicate Glass Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pharmaceutical Neutral Borosilicate Glass Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pharmaceutical Neutral Borosilicate Glass Packaging in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Neutral Borosilicate Glass Packaging Industry Trends Table 2. Pharmaceutical Neutral Borosilicate Glass Packaging Industry Drivers Table 3. Pharmaceutical Neutral Borosilicate Glass Packaging Industry Opportunities and Challenges Table 4. Pharmaceutical Neutral Borosilicate Glass Packaging Industry Restraints Table 5. Global Pharmaceutical Neutral Borosilicate Glass Packaging Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Neutral Borosilicate Glass Packaging Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume by Company (k units) & (2021-2026) Table 8. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume Share by Company (2021-2026) Table 9. Global Pharmaceutical Neutral Borosilicate Glass Packaging Average Price (USD/unit) of Company (2021-2026) Table 10. Global Pharmaceutical Neutral Borosilicate Glass Packaging Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pharmaceutical Neutral Borosilicate Glass Packaging Key Company Manufacturing Base & Headquarters Table 12. Global Pharmaceutical Neutral Borosilicate Glass Packaging Company, Product Type & Application Table 13. Global Pharmaceutical Neutral Borosilicate Glass Packaging Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceutical Neutral Borosilicate Glass Packaging by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Bottle Table 18. Significant Companies of Ampoule Table 19. Significant Companies of Oral Bottle Table 20. Significant Companies of Other Table 21. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume by Type (2021-2026) & (k units) Table 23. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume by Type (2027-2032) & (k units) Table 24. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume Share by Type (2021-2026) Table 25. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume Share by Type (2027-2032) Table 26. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type (2021-2026) Table 30. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Pharma Table 32. Significant Companies of Vaccine Table 33. Significant Companies of Other Table 34. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume by Application (2021-2026) & (k units) Table 36. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume by Application (2027-2032) & (k units) Table 37. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume Share by Application (2021-2026) Table 38. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume Share by Application (2027-2032) Table 39. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application (2021-2026) Table 43. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application (2027-2032) Table 44. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales by Region (2021-2026) & (k units) Table 46. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Market Share by Region (2021-2026) Table 47. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales by Region (2027-2032) & (k units) Table 48. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Market Share by Region (2027-2032) Table 49. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Region (2021-2026) Table 52. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Region (2027-2032) Table 54. Global Pharmaceutical Neutral Borosilicate Glass Packaging Market Average Price (USD/unit) by Region (2021-2026) Table 55. Global Pharmaceutical Neutral Borosilicate Glass Packaging Market Average Price (USD/unit) by Region (2027-2032) Table 56. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales by Country (2021-2026) & (k units) Table 59. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Market Share by Country (2021-2026) Table 60. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales by Country (2027-2032) & (k units) Table 61. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Market Share by Country (2027-2032) Table 62. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Market Share by Country (2021-2026) Table 64. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Market Share by Country (2027-2032) Table 66. Schott Company Information Table 67. Schott Business Overview Table 68. Schott Pharmaceutical Neutral Borosilicate Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. Schott Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio Table 70. Schott Recent Development Table 71. Corning (Gerresheimer) Company Information Table 72. Corning (Gerresheimer) Business Overview Table 73. Corning (Gerresheimer) Pharmaceutical Neutral Borosilicate Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Corning (Gerresheimer) Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio Table 75. Corning (Gerresheimer) Recent Development Table 76. NEG Company Information Table 77. NEG Business Overview Table 78. NEG Pharmaceutical Neutral Borosilicate Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. NEG Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio Table 80. NEG Recent Development Table 81. Cangzhou Four Stars Company Information Table 82. Cangzhou Four Stars Business Overview Table 83. Cangzhou Four Stars Pharmaceutical Neutral Borosilicate Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Cangzhou Four Stars Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio Table 85. Cangzhou Four Stars Recent Development Table 86. Triumph Junsheng Company Information Table 87. Triumph Junsheng Business Overview Table 88. Triumph Junsheng Pharmaceutical Neutral Borosilicate Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Triumph Junsheng Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio Table 90. Triumph Junsheng Recent Development Table 91. Nipro Company Information Table 92. Nipro Business Overview Table 93. Nipro Pharmaceutical Neutral Borosilicate Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Nipro Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio Table 95. Nipro Recent Development Table 96. Chengdu Golden Drum Pharmaceutical Packaging Company Information Table 97. Chengdu Golden Drum Pharmaceutical Packaging Business Overview Table 98. Chengdu Golden Drum Pharmaceutical Packaging Pharmaceutical Neutral Borosilicate Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Chengdu Golden Drum Pharmaceutical Packaging Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio Table 100. Chengdu Golden Drum Pharmaceutical Packaging Recent Development Table 101. Chongqing Zhengchuan Pharmaceutical Company Information Table 102. Chongqing Zhengchuan Pharmaceutical Business Overview Table 103. Chongqing Zhengchuan Pharmaceutical Pharmaceutical Neutral Borosilicate Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Chongqing Zhengchuan Pharmaceutical Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio Table 105. Chongqing Zhengchuan Pharmaceutical Recent Development Table 106. Shandong Linuo Company Information Table 107. Shandong Linuo Business Overview Table 108. Shandong Linuo Pharmaceutical Neutral Borosilicate Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Shandong Linuo Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio Table 110. Shandong Linuo Recent Development Table 111. Ningbo Zhengli Company Information Table 112. Ningbo Zhengli Business Overview Table 113. Ningbo Zhengli Pharmaceutical Neutral Borosilicate Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Ningbo Zhengli Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio Table 115. Ningbo Zhengli Recent Development Table 116. Shandong Pharmaceutical Glass Company Information Table 117. Shandong Pharmaceutical Glass Business Overview Table 118. Shandong Pharmaceutical Glass Pharmaceutical Neutral Borosilicate Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Shandong Pharmaceutical Glass Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio Table 120. Shandong Pharmaceutical Glass Recent Development Table 121. Wuhu Yangtze River Glass Company Information Table 122. Wuhu Yangtze River Glass Business Overview Table 123. Wuhu Yangtze River Glass Pharmaceutical Neutral Borosilicate Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Wuhu Yangtze River Glass Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio Table 125. Wuhu Yangtze River Glass Recent Development Table 126. Anhui Huaxin Medicinal Glass Company Information Table 127. Anhui Huaxin Medicinal Glass Business Overview Table 128. Anhui Huaxin Medicinal Glass Pharmaceutical Neutral Borosilicate Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Anhui Huaxin Medicinal Glass Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio Table 130. Anhui Huaxin Medicinal Glass Recent Development Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Pharmaceutical Neutral Borosilicate Glass Packaging Distributors List Table 134. Pharmaceutical Neutral Borosilicate Glass Packaging Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Pharmaceutical Neutral Borosilicate Glass Packaging Product Image Figure 2. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales (2021-2032) & (k units) Figure 5. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Pharmaceutical Neutral Borosilicate Glass Packaging Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Bottle Image Figure 10. Ampoule Image Figure 11. Oral Bottle Image Figure 12. Other Image Figure 13. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume Share by Type (2021-2032) Figure 16. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type (2021-2032) Figure 19. Pharma Image Figure 20. Vaccine Image Figure 21. Other Image Figure 22. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume Share by Application (2021-2032) Figure 25. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application (2021-2032) Figure 28. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value (2021-2032) & (US$ Million) Figure 33. North America Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value (2021-2032) & (US$ Million) Figure 39. South America Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Pharmaceutical Neutral Borosilicate Glass Packaging Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Pharmaceutical Neutral Borosilicate Glass Packaging Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Bottle
  • Ampoule
  • Oral Bottle
  • Other
Applications
  • Pharma
  • Vaccine
  • Other
Companies covered
  • Schott
  • Corning (Gerresheimer)
  • NEG
  • Cangzhou Four Stars
  • Triumph Junsheng
  • Nipro
  • Chengdu Golden Drum Pharmaceutical Packaging
  • Chongqing Zhengchuan Pharmaceutical
  • Shandong Linuo
  • Ningbo Zhengli
  • Shandong Pharmaceutical Glass
  • Wuhu Yangtze River Glass
  • Anhui Huaxin Medicinal Glass

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value (2021-2032)
  4. 1.2.2 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume (2021-2032)
  5. 1.2.3 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pharmaceutical Neutral Borosilicate Glass Packaging Market Dynamics
  1. 2.1 Pharmaceutical Neutral Borosilicate Glass Packaging Industry Trends
  2. 2.2 Pharmaceutical Neutral Borosilicate Glass Packaging Industry Drivers
  3. 2.3 Pharmaceutical Neutral Borosilicate Glass Packaging Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Neutral Borosilicate Glass Packaging Industry Restraints
3 Pharmaceutical Neutral Borosilicate Glass Packaging Market by Company
  1. 3.1 Global Pharmaceutical Neutral Borosilicate Glass Packaging Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Neutral Borosilicate Glass Packaging Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume by Company (2021-2026)
  4. 3.4 Global Pharmaceutical Neutral Borosilicate Glass Packaging Average Price by Company (2021-2026)
  5. 3.5 Global Pharmaceutical Neutral Borosilicate Glass Packaging Company Ranking (2024-2026)
  6. 3.6 Global Pharmaceutical Neutral Borosilicate Glass Packaging Company Manufacturing Base and Headquarters
  7. 3.7 Global Pharmaceutical Neutral Borosilicate Glass Packaging Company Product Type and Application
  8. 3.8 Global Pharmaceutical Neutral Borosilicate Glass Packaging Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pharmaceutical Neutral Borosilicate Glass Packaging Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pharmaceutical Neutral Borosilicate Glass Packaging Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pharmaceutical Neutral Borosilicate Glass Packaging Market by Type
  1. 4.1 Pharmaceutical Neutral Borosilicate Glass Packaging Type Introduction
  2. 4.1.1 Injection Bottle
  3. 4.1.2 Ampoule
  4. 4.1.3 Oral Bottle
  5. 4.1.4 Other
  6. 4.2 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume by Type
  7. 4.2.1 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Type
  11. 4.3.1 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Type (2021-2032)
  13. 4.3.3 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type (2021-2032)
5 Pharmaceutical Neutral Borosilicate Glass Packaging Market by Application
  1. 5.1 Pharmaceutical Neutral Borosilicate Glass Packaging Application Introduction
  2. 5.1.1 Pharma
  3. 5.1.2 Vaccine
  4. 5.1.3 Other
  5. 5.2 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume by Application
  6. 5.2.1 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Application
  10. 5.3.1 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application (2021-2032)
6 Pharmaceutical Neutral Borosilicate Glass Packaging Regional Sales and Value Analysis
  1. 6.1 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales by Region (2027-2032)
  5. 6.3 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Region (2027-2032)
  9. 6.5 Global Pharmaceutical Neutral Borosilicate Glass Packaging Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value (2021-2032)
  12. 6.6.2 North America Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value (2021-2032)
  15. 6.7.2 Europe Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value (2021-2032)
  21. 6.9.2 South America Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Neutral Borosilicate Glass Packaging Country-level Sales and Value Analysis
  1. 7.1 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales by Country (2021-2032)
  4. 7.3.1 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales by Country (2021-2026)
  5. 7.3.2 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales by Country (2027-2032)
  6. 7.4 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pharmaceutical Neutral Borosilicate Glass Packaging Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Schott
  2. 8.1.1 Schott Company Information
  3. 8.1.2 Schott Business Overview
  4. 8.1.3 Schott Pharmaceutical Neutral Borosilicate Glass Packaging Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Schott Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio
  6. 8.1.5 Schott Recent Developments
  7. 8.2 Corning (Gerresheimer)
  8. 8.2.1 Corning (Gerresheimer) Company Information
  9. 8.2.2 Corning (Gerresheimer) Business Overview
  10. 8.2.3 Corning (Gerresheimer) Pharmaceutical Neutral Borosilicate Glass Packaging Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Corning (Gerresheimer) Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio
  12. 8.2.5 Corning (Gerresheimer) Recent Developments
  13. 8.3 NEG
  14. 8.3.1 NEG Company Information
  15. 8.3.2 NEG Business Overview
  16. 8.3.3 NEG Pharmaceutical Neutral Borosilicate Glass Packaging Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 NEG Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio
  18. 8.3.5 NEG Recent Developments
  19. 8.4 Cangzhou Four Stars
  20. 8.4.1 Cangzhou Four Stars Company Information
  21. 8.4.2 Cangzhou Four Stars Business Overview
  22. 8.4.3 Cangzhou Four Stars Pharmaceutical Neutral Borosilicate Glass Packaging Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Cangzhou Four Stars Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio
  24. 8.4.5 Cangzhou Four Stars Recent Developments
  25. 8.5 Triumph Junsheng
  26. 8.5.1 Triumph Junsheng Company Information
  27. 8.5.2 Triumph Junsheng Business Overview
  28. 8.5.3 Triumph Junsheng Pharmaceutical Neutral Borosilicate Glass Packaging Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Triumph Junsheng Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio
  30. 8.5.5 Triumph Junsheng Recent Developments
  31. 8.6 Nipro
  32. 8.6.1 Nipro Company Information
  33. 8.6.2 Nipro Business Overview
  34. 8.6.3 Nipro Pharmaceutical Neutral Borosilicate Glass Packaging Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Nipro Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio
  36. 8.6.5 Nipro Recent Developments
  37. 8.7 Chengdu Golden Drum Pharmaceutical Packaging
  38. 8.7.1 Chengdu Golden Drum Pharmaceutical Packaging Company Information
  39. 8.7.2 Chengdu Golden Drum Pharmaceutical Packaging Business Overview
  40. 8.7.3 Chengdu Golden Drum Pharmaceutical Packaging Pharmaceutical Neutral Borosilicate Glass Packaging Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Chengdu Golden Drum Pharmaceutical Packaging Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio
  42. 8.7.5 Chengdu Golden Drum Pharmaceutical Packaging Recent Developments
  43. 8.8 Chongqing Zhengchuan Pharmaceutical
  44. 8.8.1 Chongqing Zhengchuan Pharmaceutical Company Information
  45. 8.8.2 Chongqing Zhengchuan Pharmaceutical Business Overview
  46. 8.8.3 Chongqing Zhengchuan Pharmaceutical Pharmaceutical Neutral Borosilicate Glass Packaging Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Chongqing Zhengchuan Pharmaceutical Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio
  48. 8.8.5 Chongqing Zhengchuan Pharmaceutical Recent Developments
  49. 8.9 Shandong Linuo
  50. 8.9.1 Shandong Linuo Company Information
  51. 8.9.2 Shandong Linuo Business Overview
  52. 8.9.3 Shandong Linuo Pharmaceutical Neutral Borosilicate Glass Packaging Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Shandong Linuo Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio
  54. 8.9.5 Shandong Linuo Recent Developments
  55. 8.10 Ningbo Zhengli
  56. 8.10.1 Ningbo Zhengli Company Information
  57. 8.10.2 Ningbo Zhengli Business Overview
  58. 8.10.3 Ningbo Zhengli Pharmaceutical Neutral Borosilicate Glass Packaging Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Ningbo Zhengli Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio
  60. 8.10.5 Ningbo Zhengli Recent Developments
  61. 8.11 Shandong Pharmaceutical Glass
  62. 8.11.1 Shandong Pharmaceutical Glass Company Information
  63. 8.11.2 Shandong Pharmaceutical Glass Business Overview
  64. 8.11.3 Shandong Pharmaceutical Glass Pharmaceutical Neutral Borosilicate Glass Packaging Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Shandong Pharmaceutical Glass Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio
  66. 8.11.5 Shandong Pharmaceutical Glass Recent Developments
  67. 8.12 Wuhu Yangtze River Glass
  68. 8.12.1 Wuhu Yangtze River Glass Company Information
  69. 8.12.2 Wuhu Yangtze River Glass Business Overview
  70. 8.12.3 Wuhu Yangtze River Glass Pharmaceutical Neutral Borosilicate Glass Packaging Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Wuhu Yangtze River Glass Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio
  72. 8.12.5 Wuhu Yangtze River Glass Recent Developments
  73. 8.13 Anhui Huaxin Medicinal Glass
  74. 8.13.1 Anhui Huaxin Medicinal Glass Company Information
  75. 8.13.2 Anhui Huaxin Medicinal Glass Business Overview
  76. 8.13.3 Anhui Huaxin Medicinal Glass Pharmaceutical Neutral Borosilicate Glass Packaging Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Anhui Huaxin Medicinal Glass Pharmaceutical Neutral Borosilicate Glass Packaging Product Portfolio
  78. 8.13.5 Anhui Huaxin Medicinal Glass Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceutical Neutral Borosilicate Glass Packaging Value Chain Analysis
  2. 9.1.1 Pharmaceutical Neutral Borosilicate Glass Packaging Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceutical Neutral Borosilicate Glass Packaging Sales Mode & Process
  6. 9.2 Pharmaceutical Neutral Borosilicate Glass Packaging Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceutical Neutral Borosilicate Glass Packaging Distributors
  9. 9.2.3 Pharmaceutical Neutral Borosilicate Glass Packaging Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst